Cite
Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis
MLA
Frédéric Blanc, et al. “Effect of Natalizumab on Clinical and Radiological Disease Activity in a French Cohort of Patients with Relapsing-Remitting Multiple Sclerosis.” Journal of Neurology, vol. 259, no. 6, Oct. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....120d6dcd5969e765c6753edc9761d1f9&authtype=sso&custid=ns315887.
APA
Frédéric Blanc, J. de Seze, Hélène Zéphir, Jean-Claude Ongagna, Patrick Vermersch, Arnaud Lacour, Marie-Céline Fleury, Anne-Sophie Berteloot, A. Melin, Nicolas Collongues, & Olivier Outteryck. (2011). Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis. Journal of Neurology, 259(6).
Chicago
Frédéric Blanc, J. de Seze, Hélène Zéphir, Jean-Claude Ongagna, Patrick Vermersch, Arnaud Lacour, Marie-Céline Fleury, et al. 2011. “Effect of Natalizumab on Clinical and Radiological Disease Activity in a French Cohort of Patients with Relapsing-Remitting Multiple Sclerosis.” Journal of Neurology 259 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....120d6dcd5969e765c6753edc9761d1f9&authtype=sso&custid=ns315887.